Skin and subcutaneous tissue thickness at insulin injection sites in Chinese diabetes patients: Clinical implications

Diabetes and Metabolism

Volumn 42, Issue 5, 2016, Pages 374-377

  Wang, W ^a   Guo, X ^a   Shen, G ^a   Bai, G ^b   Wei, Z ^c   Liu, J ^c   Hirsch, L ^d   Strauss, K ^e  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c Unit 02B   (China)

^d BD Technologies   (United States)

^e BD   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ABDOMEN; ADULT; AGE DISTRIBUTION; AGED; BODY MASS; BUTTOCK; CHINESE; DIABETIC PATIENT; FEMALE; HUMAN; INJECTION SITE; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE; THIGH; VERY ELDERLY; ADOLESCENT; ANATOMY AND HISTOLOGY; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT ANALYSIS; DIABETES MELLITUS; MIDDLE AGED; SKIN; SUBCUTANEOUS DRUG ADMINISTRATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; SKIN; SUBCUTANEOUS TISSUE; YOUNG ADULT;

EID: 84973454822     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2016.04.010     Document Type: Letter

References (13)

1. [1] Xu, Y., Wang, L., He, J., Bi, Y., Li, M., Wang, T., et al. Prevalence and control of diabetes in Chinese adults. JAMA 310 (2013), 948–959.
2. [2] Gibney, M.A., Arce, C.H., Byron, K.J., Hirsch, L., Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 26 (2010), 1519–1530.
3. [3] LoPresti, D., Ingegnosi, C., Strauss, K., Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection. Pediatr Diabetes 13 (2012), 525–533.
4. [4] Sim, K.H., Hwang, M.S., Kim, S.Y., Lee, H.M., Chang, J.Y., Lee, M.K., The appropriateness of the length of insulin needles based on determination of skin and subcutaneous fat thickness in the abdomen and upper arm in patients with type 2 diabetes. Diabetes Metab J 38 (2014), 120–133.
5. [5] Catambing, I., Villa, M., Ultrasonographic measurement of skin and subcutaneous thickness at insulin injection sites among adult Filipinos with diabetes. JAFES 29 (2014), 24–32.
6. [6] Strauss K. Personal communication regarding 2015 Insulin Injection Questionnaire (ITQ) survey.
7. [7] Hirsch, L., Byron, K., Gibney, M., Intramuscular risk at insulin injection sites-measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Diabetes Technol Ther 16 (2014), 867–873.
8. [8] Hirsch, L., Klaff, L., Bailey, T., Gibney, M., Albanese, J., Qu, S., Kassler-Taub, K., Comparative glycemic control, safety and patient ratings for a new 4 mm\32G insulin pen needle in adults with diabetes. Curr Med Res Opin 26 (2010), 1531–1541.
9. [9] Miwa, T., Itoh, R., Kobayashi, T., Tanabe, T., Shikuma, J., Takahashi, T., et al. Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes. Diabetes Technol Ther 14 (2012), 1084–1090.
10. [10] Nagai, Y., Ohshige, T., Arai, K., Kobayashi, H., Sada, Y., Ohmori, S., Comparison between shorter straight and thinner microtapered insulin injection needles. Diab Tech Ther 15 (2013), 550–555.
11. [11] Hirose, T., Ogihara, T., Tozaka, S., Kanderian, S., Watada, H., Identification and comparison of insulin pharmacokinetics injected with a new 4-mm needle vs. 6- and 8-mm needles accounting for endogenous insulin and C-peptide secretion kinetics in non-diabetic adult males. J Diabetes Investig 4 (2013), 287–296.
12. [12] Jiajia, J., Qingqing, L., Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010. CMRO 30 (2014), 1087–1093.
13. [13] Chinese Diabetes Society, Chinese clinical guidelines for diabetic injection technology. Chin J Gen Pract 11:5 (2012), 319–321.